Bivalirudin direct thrombin inhibitor
WebApr 6, 2024 · Bivalirudin is a medication used to manage and treat patients undergoing percutaneous coronary intervention for acute myocardial infarction. It is in the direct … http://clsjournal.ascls.org/content/ascls/26/1/54.full.pdf
Bivalirudin direct thrombin inhibitor
Did you know?
WebOct 23, 2024 · Argatroban and bivalirudin are direct thrombin inhibitors (DTIs) used for the treatment of heparin-induced thrombocytopenia (HIT). The purpose of this study was to determine whether either agent offered an advantage in efficacy and ability to remain within the targeted therapeutic anticoagulation range. WebDiscussion: Bivalirudin is a direct thrombin inhibitor frequently used off-label for the medical management of heparin-induced thrombocytopenia. It typically exhibits predictable, dose-dependent anticoagulation. Heparin-induced thrombocytopenia was suspected in 2 of the 3 cases and confirmed in 1. In all 3 patients, target aPTT was initially ...
WebBivalirudin is an intravenous direct thrombin inhibitor that is a congener of hirudin, an anticoagulant first identified in leeches. It is a reversible inhibitor of thrombin and requires dose adjustment to maintain anticoagulation parameters within an … WebBivalirudin is a direct thrombin inhibitor (DTI) frequently used for anticoagulation in the setting of invasive cardiology, particularly percutaneous coronary intervention (PCI). …
Web摘要: The objectives of the present study were to assess pharmacokinetics, pharmacodynamics, tolerability and safety of intravenous administration of bivalirudin, a direct thrombin inhibitor, in healthy Chinese subjects. 48 subjects were equally divided into 4 groups (0.5 mg/kg, 0.75 mg/kg, 1.05 mg/kg intravenous bolus, and 0.75 mg/kg … WebJan 1, 2011 · The objectives of the present study were to assess pharmacokinetics, pharmacodynamics, tolerability and safety of intravenous administration of bivalirudin, a direct thrombin inhibitor, in healthy Chinese subjects. 48 subjects were equally divided into 4 groups (0.5 mg/kg, 0.75 mg/kg, 1.05 mg/kg intravenous bolus, and 0.75 mg/kg …
WebApr 7, 2024 · Bivalirudin (Angiomax The Medicines Company, Parsippany, NJ; previous name hirulog) has been studied in subtherapeutic doses (Thrombin Inhibition in Myocardial Ischemia [TIMI] 7), and in...
WebBivalirudin is administered via continuous intravenous infusion, is removed by a combination of proteolytic cleavage by thrombin and renal clearance mechanisms, and can inhibit both soluble and clot-bound thrombin. porphyry indicator mineralsWebThe choice of a direct thrombin inhibitors as a heparin alternative for CPB is consistent with published studies showing that the direct thrombin inhibitors hirudin, argatroban, and bivalirudin, have all been used successfully in human CPB. 16–18 Bivalirudin is currently recommended as a heparin alternative for patients with heparin-induced ... sharp pains in right chestWebMay 18, 2005 · The univalent direct thrombin inhibitors are low molecular weight peptides such as argatroban, melagatran (the active form of ximelagatran), efegatran and inogatran . Bivalent direct thrombin inhibitors are hirudin (desirudin or lepirudin) and bivalirudin (previously called hirulog). porphyry nodes mtgWebJun 19, 2024 · Bivalirudin acts as a specific and reversible direct thrombin inhibitor; it binds to the catalytic and anionic exosite of both circulating and clot-bound thrombin. … porphyry mineralization in the tethyan orogenWebJan 1, 2002 · Bivalirudin's structure can be divided into 3 distinct domains. The first contains the 12-amino acid carboxyl terminal region of hirudin, which was found to be … sharp pains in pelvic areaWebArgatroban and bivalirudin are parenteral direct inhibitors of the activity of thrombin, but, unlike heparin, can inhibit both soluble as well as clot-bound thrombin. These agents do not require antithrombin as a cofactor for activity. The parenteral direct thrombin inhibitors (DTIs) can be used in … porphyry imageWebFeb 14, 2024 · Bivalirudin (Angiomax; The Medicines Company, Parsippany, NJ), a direct thrombin inhibitor, has found increasing utilization as a heparin alternative in the pediatric population, most commonly for the treatment of thrombosis secondary to heparin-induced thrombocytopenia. sharp pains in my right temple area